Menu

Drug Class Guide

GLP-1 Medications (GLP-1 Receptor Agonists)

Injections and pills that lower blood sugar and appetite, used for type 2 diabetes, weight management and, for some, heart protection.

How GLP-1 Medications Work

GLP-1 is a hormone the gut releases after a meal. These medicines act on the same receptor but last far longer. They help the pancreas release insulin when blood sugar is high, lower glucagon, slow stomach emptying and act on appetite centers in the brain, so people feel full sooner. Tirzepatide also activates a second receptor, GIP.

What GLP-1 Medications Treat

GLP-1 Medications in Our Medication Guide

Common Side Effects

Nausea, vomiting, diarrhea and constipation are the most common side effects. They are usually worst in the first weeks and after each dose increase, which is why every medicine in the class starts low and steps up slowly. Used without insulin or a sulfonylurea, they rarely cause low blood sugar.

Important Cautions

  • Most carry a boxed warning about thyroid C-cell tumors seen in rodents; they are not used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2.
  • Severe stomach pain that spreads to the back may be pancreatitis and needs prompt care.
  • Tell your surgeon or anesthesiologist that you take one before any procedure with sedation, because food can stay in the stomach longer.
  • Tirzepatide and orforglipron can make birth control pills less reliable after starting and after each dose increase.

Side-by-Side Comparisons

Common Questions About GLP-1 Medications

Which GLP-1 medication causes the most weight loss?

In clinical trials, tirzepatide produced the largest average weight loss, about 20 percent of body weight over 72 weeks, compared with about 14 percent for semaglutide in a head-to-head study. The daily pill orforglipron averaged roughly 11 percent. Dulaglutide, liraglutide at diabetes doses and exenatide lead to smaller losses. Individual results vary widely.

Are all GLP-1 medications approved for weight loss?

No. Wegovy (semaglutide), Zepbound (tirzepatide), Saxenda (liraglutide) and Foundayo (orforglipron) are approved for chronic weight management. Ozempic, Rybelsus, Mounjaro, Victoza and Trulicity are approved for type 2 diabetes. Insurance plans usually follow the approved use, so the brand prescribed depends on your diagnosis.

Can you switch from one GLP-1 medication to another?

Yes, and it is common when coverage changes, side effects persist or goals are not met. Doses do not convert one-to-one, so your doctor chooses the starting dose of the new medicine, often a lower step, and then increases it. Two GLP-1 medicines are never taken at the same time.

Do you have to stay on a GLP-1 medication for life?

Type 2 diabetes and obesity are long-term conditions, and the benefits last while the medicine is taken. In trials, most people regained much of the lost weight within a year of stopping. Some people step down to a lower maintenance dose. Any plan to stop is best made with your doctor.

This guide is general information, not a substitute for advice about your own medicines. Do not start, stop or switch a medication without talking with your doctor. Questions about a prescription? Our internal medicine team can help.

Call (727) 820-7800

References

Trusted Resources for GLP-1 Medications

For further reading, our team recommends the following authoritative sources. These external links open in a new tab.